GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dezhan Healthcare Co Ltd (SZSE:000813) » Definitions » Buyback Yield %

Dezhan Healthcare Co (SZSE:000813) Buyback Yield % : 0.00 (As of May. 04, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Dezhan Healthcare Co Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Dezhan Healthcare Co's current buyback yield was 0.00%.


Dezhan Healthcare Co Buyback Yield % Historical Data

The historical data trend for Dezhan Healthcare Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dezhan Healthcare Co Buyback Yield % Chart

Dezhan Healthcare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dezhan Healthcare Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dezhan Healthcare Co's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Dezhan Healthcare Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dezhan Healthcare Co's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dezhan Healthcare Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Dezhan Healthcare Co's Buyback Yield % falls into.


;
;

Dezhan Healthcare Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Dezhan Healthcare Co's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 6776.31228
=0.00%

Dezhan Healthcare Co's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 7166.00436
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


Dezhan Healthcare Co Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Dezhan Healthcare Co's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dezhan Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235 Yin Chuan Road, Xinjiang, Urumqi, CHN, 830054
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
Executives
Liu Ye Executives
Zhang Yong Director
Gao Li Supervisors
Sun Ji Lu Supervisors
Wang Xiao Ping Director

Dezhan Healthcare Co Headlines

No Headlines